Medrx Co., Ltd.(JP:4586)
Â¥47.00-3.00 (-6.00%)
JP:4586
Medrx Co., Ltd. financials statements
Â¥47.00
At close:-3.00 (-6.00%)
Want to see JP:4586 full AI Analyst Report?
Medrx Co., Ltd. (4586) Ratios
0 Followers
Medrx Co., Ltd. Ratios
JP:4586's free cash flow for Q2 2026 was ¥0.00. For the 2026 fiscal year, JP:4586's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 23.62 | 19.73 | 17.85 | 6.87 | 13.95 |
| Quick Ratio | 23.40 | 19.64 | 17.75 | 6.82 | 13.86 |
| Cash Ratio | 22.71 | 18.83 | 17.20 | 6.29 | 13.54 |
| Solvency Ratio | -8.51 | -7.18 | -6.95 | -5.74 | -6.53 |
| Operating Cash Flow Ratio | -11.49 | -7.65 | -9.13 | -6.79 | -7.34 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | ¥ 1.72B | ¥ 1.97B | ¥ 1.66B | ¥ 901.47M | ¥ 1.60B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.05 | 1.05 | 1.07 | 1.15 | 1.08 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | -559.87 | -677.54 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | -583.55 | -720.45 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.07 | 0.07 |
| Net Debt to EBITDA | 1.89 | 2.62 | 1.94 | 0.94 | 1.71 |
| Profitability Margins | |||||
| Gross Profit Margin | 88.23% | 84.98% | 89.66% | 17.56% | 72.90% |
| EBIT Margin | -735.45% | -307.48% | -3207.18% | -1847.32% | -12658.69% |
| EBITDA Margin | -724.62% | -292.58% | -3050.06% | -1769.28% | -11936.08% |
| Operating Profit Margin | -735.45% | -307.48% | -3217.24% | -1847.32% | -12709.29% |
| Pretax Profit Margin | -722.22% | -311.24% | -3207.17% | -1864.96% | -12676.34% |
| Net Profit Margin | -731.84% | -312.80% | -3213.79% | -1868.04% | -12692.61% |
| Continuous Operations Profit Margin | -731.84% | -312.80% | -3213.79% | -1868.04% | -12692.60% |
| Net Income Per EBT | 101.33% | 100.50% | 100.21% | 100.17% | 100.13% |
| EBT Per EBIT | 98.20% | 101.22% | 99.69% | 100.95% | 99.74% |
| Return on Assets (ROA) | -43.45% | -35.46% | -45.42% | -79.47% | -50.26% |
| Return on Equity (ROE) | -45.75% | -37.21% | -48.47% | -91.63% | -54.20% |
| Return on Capital Employed (ROCE) | -45.28% | -36.55% | -47.80% | -88.61% | -53.52% |
| Return on Invested Capital (ROIC) | -45.28% | -36.55% | -47.80% | -88.61% | -53.52% |
| Return on Tangible Assets | -43.45% | -35.46% | -45.42% | -79.47% | -50.26% |
| Earnings Yield | -16.15% | -22.63% | -17.75% | -46.11% | -38.77% |
| Efficiency Ratios | |||||
| Receivables Turnover | 9.99 | 5.82 | 0.88 | 3.90 | 0.36 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
| Inventory Turnover | 0.89 | 3.87 | 0.30 | 5.88 | 0.19 |
| Fixed Asset Turnover | 0.67 | 2.09 | 0.16 | 0.26 | 0.03 |
| Asset Turnover | 0.06 | 0.11 | 0.01 | 0.04 | 0.00 |
| Working Capital Turnover Ratio | 0.07 | 0.14 | 0.02 | 0.05 | 0.00 |
| Cash Conversion Cycle | 446.45 | 157.17 | 1632.26 | 155.65 | -10131.96 |
| Days of Sales Outstanding | 36.55 | 62.76 | 415.60 | 93.55 | 1006.26 |
| Days of Inventory Outstanding | 409.90 | 94.42 | 1216.67 | 62.10 | 1901.94 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 13040.16 |
| Operating Cycle | 446.45 | 157.17 | 1632.26 | 155.65 | 2908.20 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -16.53 | -18.47 | -26.25 | -42.32 | -43.25 |
| Free Cash Flow Per Share | -18.07 | -18.47 | -26.27 | -42.39 | -43.37 |
| Dividend Paid and CapEx Coverage Ratio | -10.73 | -3030.19 | -1202.90 | -548.16 | -363.37 |
| Capital Expenditure Coverage Ratio | -10.73 | -3030.19 | -1202.90 | -548.16 | -363.37 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -6.93 | -3.11 | -31.48 | -18.04 | -110.62 |
| Free Cash Flow Yield | -16.73% | -22.53% | -17.40% | -44.62% | -33.88% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -6.19 | -4.42 | -5.63 | -2.17 | -2.58 |
| Price-to-Sales (P/S) Ratio | 45.31 | 13.82 | 181.08 | 40.51 | 327.40 |
| Price-to-Book (P/B) Ratio | 2.83 | 1.64 | 2.73 | 1.99 | 1.40 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.98 | -4.44 | -5.75 | -2.24 | -2.95 |
| Price-to-Operating Cash Flow Ratio | -6.53 | -4.44 | -5.75 | -2.24 | -2.96 |
| Price-to-Earnings Growth (PEG) Ratio | 1.03 | 0.14 | 0.15 | 0.19 | 0.09 |
| Enterprise Value Multiple | -4.36 | -2.10 | -3.99 | -1.35 | -1.03 |
| Enterprise Value | 4.05B | 1.59B | 3.53B | 1.42B | 1.03B |
| EV to EBITDA | -4.36 | -2.10 | -3.99 | -1.35 | -1.03 |
| EV to Sales | 31.61 | 6.15 | 121.77 | 23.80 | 123.37 |
| EV to Free Cash Flow | -4.17 | -1.98 | -3.86 | -1.32 | -1.11 |
| EV to Operating Cash Flow | -4.56 | -1.98 | -3.87 | -1.32 | -1.12 |
| Tangible Book Value Per Share | 38.13 | 49.88 | 55.34 | 47.81 | 91.56 |
| Shareholders’ Equity Per Share | 38.13 | 49.88 | 55.29 | 47.81 | 91.56 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 2.38 | 5.93 | 0.83 | 2.35 | 0.39 |
| Net Income Per Share | -17.44 | -18.56 | -26.80 | -43.81 | -49.62 |
| Tax Burden | 1.01 | 1.01 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.98 | 1.01 | 1.00 | 1.01 | 1.00 |
| Research & Development to Revenue | 6.55 | 3.14 | 25.41 | 15.48 | 95.09 |
| SG&A to Revenue | 1.69 | 0.78 | 1.59 | 0.86 | 6.23 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.09 | 0.00 |
| Income Quality | 0.95 | 1.00 | 0.98 | 0.97 | 0.87 |
Currency in JPY

